Results 21 to 30 of about 1,139,909 (203)

B-Cell Follicles in the Secondary Lymphatic Tissues Act as a Critical Microanatomical Niche for Sustained Viral Replication, Virus-Host Interaction and Damage During Chronic SIV Infection of Rhesus Macaques. [PDF]

open access: yesJ Med Virol
ABSTRACT Most people living with HIV‐1 (HIV) are diagnosed during the chronic stage of infection, at which point viral setpoint has been established and a substantial immunopathologic damage in the secondary lymphatic tissues (LTs) has been induced. To better characterize virus‐host interaction and immunopathologic damage in LTs, we investigated viral ...
Cheng Y   +5 more
europepmc   +2 more sources

Ecological Impacts of Apiaries [PDF]

open access: yes, 2021
The Come Clean, Go Green competition is a program dedicated to making Lewis a more sustainable campus with ideas from Lewis Students across all disciplines.
Lewis University
core   +1 more source

The prevalence of secretor status and co-expression of lewis antigen in voluntary blood donors

open access: yesAsian Journal of Medical Sciences, 2016
Background: Blood group substances are present in soluble form in a majority of individuals in secretion such as saliva and body fl uids. Secretor status refers to the presence (SeSe and Sese) or absence (sese) of secretor gene which secrete ABH ...
R Raj Bharath
doaj   +1 more source

High expressions of BCL6 and Lewis y antigen are correlated with high tumor burden and poor prognosis in epithelial ovarian cancer

open access: yesTumor Biology, 2017
Aberrant regulation of BCL6 plays crucial oncogenic roles in various malignant tumors; howbeit, the function of BCL6 in tumorigenesis of ovarian cancer remains unclear. The aim of this study is to investigate the role of BCL6 in ovarian cancer.
Liancheng Zhu   +9 more
doaj   +1 more source

Bombay and Lewis phenotype testing in correlation with leukocyte adhesion deficiency type II: The blood bank's role in diagnosis

open access: yesJournal of Applied Hematology, 2020
Leukocyte adhesion deficiency type II (LAD II) is a rare hereditary disorder caused by the mutation in the guanosine diphosphate-fucose transporter gene (SLC35C1).
Khalid Batarfi   +4 more
doaj   +1 more source

Major and minor subgroup profile of blood in patients receiving multiple transfusions and donors

open access: yesAsian Journal of Transfusion Science, 2022
OBJECTIVE: It was aimed to profile the blood subgroups of our region and to reveal the prevalence of auto/alloimmune sensitization in patients who had to undergo multiple erythrocyte transfusions and to establish the sensitization profile by screening ...
Mehmet Fatih Orhan   +3 more
doaj   +1 more source

Optimization of blood safety through essential characterization of naturally occurring lewis antibody

open access: yesGlobal Journal of Transfusion Medicine, 2018
Background: Lewis (Le) antibodies are usually naturally occurring; however, they may be clinically significant, may be immunoglobulin G (IgG) type, and may cause hemolytic transfusion reactions.
Sudipta Sekhar Das, Ritam Chakrabarty
doaj   +1 more source

Lipopolysaccharide diversity evolving in Helicobacter pylori communities through genetic modifications in fucosyltransferases. [PDF]

open access: yesPLoS ONE, 2008
Helicobacter pylori persistently colonizes the gastric mucosa of half the human population. It is one of the most genetically diverse bacterial organisms and subvariants are continuously emerging within an H. pylori population.
Christina Nilsson   +5 more
doaj   +1 more source

Vascularized Composite Allograft Rejection Is Delayed by Intrajejunal Treatment with Donor Splenocytes without Concomitant Immunosuppressants

open access: yesClinical and Developmental Immunology, 2012
Background. Mucosal or oral tolerance, an established method for inducing low-risk antigen-specific hyporesponsiveness, has not been investigated in vascularized composite allograft (VCA) research. We studied its effects on recipient immune responses and
Christopher Glenn Wallace   +7 more
doaj   +1 more source

A Novel Bispecific Antibody Targeting CD3 and Lewis Y with Potent Therapeutic Efficacy against Gastric Cancer

open access: yesBiomedicines, 2021
Lewis Y antigen, a glycan highly expressed on most epithelial cancers, was targeted for cancer treatment but lacked satisfactory results in some intractable and refractory cancers.
Jie Chen   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy